Search Results
| No. |
VISDB ID▲▼ |
Virus Name▲▼ |
Subtype▲▼ |
Virus Genome▲▼ |
Breakpoint 1▲▼ |
Breakpoint 2▲▼ |
Human Genome▲▼ |
Chr▲▼ |
Start▲▼ |
End▲▼ |
Loci▲▼ |
Target Gene▲▼ |
Sample Type▲▼ |
Disease▲▼ |
Method▲▼ |
PubMed ID▲▼ |
Year▲▼ |
Curated Way▲▼ |
| 1831 |
TVIS20016366
|
Human Papillomavirus |
HPV16 |
- |
5640 |
- |
hg19 |
chr2 |
151525163 |
151525163 |
q23.3 |
NEB |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
| 1832 |
TVIS20016367
|
Human Papillomavirus |
HPV16 |
- |
742 |
- |
hg19 |
chr20 |
33669375 |
33669375 |
q11.22 |
NECAB3 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
| 1833 |
TVIS20016368
|
Human Papillomavirus |
HPV16 |
- |
3358 |
- |
hg19 |
chr20 |
33669375 |
33669375 |
q11.22 |
NECAB3 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
| 1834 |
TVIS20016369
|
Human Papillomavirus |
HPV16 |
- |
5640 |
- |
hg19 |
chr20 |
33669143 |
33669143 |
q11.22 |
NECAB3 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
| 1835 |
TVIS20016370
|
Human Papillomavirus |
HPV16 |
- |
563 |
- |
hg19 |
chr20 |
33669375 |
33669375 |
q11.22 |
NECAB3 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
| 1836 |
TVIS20016371
|
Human Papillomavirus |
HPV16 |
- |
84 |
- |
hg19 |
chr20 |
33670684 |
33670684 |
q11.22 |
NECAB3 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
| 1837 |
TVIS20016372
|
Human Papillomavirus |
HPV16 |
- |
5640 |
- |
hg19 |
chr20 |
33669375 |
33669375 |
q11.22 |
NECAB3 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
| 1838 |
TVIS20016373
|
Human Papillomavirus |
HPV16 |
- |
5637 |
- |
hg19 |
chr20 |
21512176 |
21512176 |
p11.22 |
NKX2-2, NKX2-2-AS1 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
| 1839 |
TVIS20016374
|
Human Papillomavirus |
HPV16 |
- |
878 |
- |
hg19 |
chr20 |
21513632 |
21513632 |
p11.22 |
NKX2-2, NKX2-2-AS1 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
| 1840 |
TVIS20016375
|
Human Papillomavirus |
HPV16 |
- |
880 |
- |
hg19 |
chr20 |
21514043 |
21514043 |
p11.22 |
NKX2-2 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |